Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Operating Profit Margin
since 2005

Microsoft Excel

Paying user area

Try for free

Edwards Lifesciences Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Edwards Lifesciences Corp., operating profit margin, long-term trends, calculation

Microsoft Excel
Operating profit margin = 100 × Operating income1 ÷ Net sales1
Dec 31, 2021 = 100 × ÷
Dec 31, 2020 = 100 × ÷
Dec 31, 2019 = 100 × ÷
Dec 31, 2018 = 100 × ÷
Dec 31, 2017 = 100 × ÷
Dec 31, 2016 = 100 × ÷
Dec 31, 2015 = 100 × ÷
Dec 31, 2014 = 100 × ÷
Dec 31, 2013 = 100 × ÷
Dec 31, 2012 = 100 × ÷
Dec 31, 2011 = 100 × ÷
Dec 31, 2010 = 100 × ÷
Dec 31, 2009 = 100 × ÷
Dec 31, 2008 = 100 × ÷
Dec 31, 2007 = 100 × ÷
Dec 31, 2006 = 100 × ÷
Dec 31, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Net Sales Trend
Net sales demonstrated a consistent upward trajectory from 2005 through 2021. Beginning at $997.9 million in 2005, sales steadily increased each year, reaching $5.23 billion in 2021. This reflects a strong growth momentum over the 16-year period, with particularly notable increases between 2014 and 2021.
Operating Income Trend
Operating income data is available starting from 2014. The figures show fluctuations within this period. In 2014, operating income was $751.2 million, rising sharply to $1.089 billion in 2015, followed by a notable decrease to $748.2 million in 2016. Subsequent years saw recovery and increases, with income reaching $1.69 billion in 2021. Despite some variability, the overall trend from 2014 to 2021 is upward, indicating improved operational profitability in recent years.
Operating Profit Margin Trend
Operating profit margin data is also limited to the years 2014 through 2021. Margins ranged between approximately 20% and 32.3% during this period. Initial improvement is seen from 25.35% in 2014 to a peak of 31.71% in 2015, followed by a decline to around 20.1% in 2016. Thereafter, margins fluctuated but generally remained above 20%, culminating in a high of 32.3% in 2021. This indicates varying efficiency in controlling operating costs relative to net sales, but an overall positive trend in margin expansion by 2021.
Summary of Financial Performance
The company exhibited significant growth in net sales over the entire period analyzed, suggesting successful market penetration and expansion strategies. Operating income and profit margins, although available for only part of the period, reflect intermittent volatility but an overall tendency toward improvement, particularly in recent years. This implies enhanced operational efficiency and profitability aligned with growing sales volumes. The combined trends demonstrate a strengthening financial position with increased top-line revenue supported by improving profitability metrics.

Comparison to Competitors

Edwards Lifesciences Corp., operating profit margin, long-term trends, comparison to competitors

Microsoft Excel
Edwards Lifesciences Corp. Abbott Laboratories CVS Health Corp. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).